Compare Globus Medical Inc. Class A Common Stock (GMED) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Wolfspeed Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Wolfspeed Inc trades at $23.85 (market cap $1.51B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 6.8× Wolfspeed Inc's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Wolfspeed Inc for 20 Days on average.
| GMED | WOLF | |
|---|---|---|
Market Cap | $10.25B | $1.51B |
Volume | 1,108,124 | 3,682,639 |
Sector | Health | Technology |
52-Week High | $96.82 | $73.68 |
52-Week Low | $58.33 | $14.80 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $9.76B | $2.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Wolfspeed (WOLF) trades at $28.67, up 2.25% today, amid mixed technical signals with a bearish moving average trend but bullish oscillators. The company shows severe financial strain with negative gross margins of -16.05% and net losses of -$1.61B in 2025, though 2026 projects a return to profitability. Recent news highlights expansion of 200mm silicon carbide technology and ongoing investor litigation investigations.
The stock presents high-risk speculative potential with analyst consensus target of $54.32 suggesting significant upside, but requires successful execution on revenue growth and margin improvement. Key risks include persistent negative profitability, high debt burden, and competitive pressures in the semiconductor materials sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
